Home › Hidradenitis Suppurativa › Alabama
Hidradenitis Suppurativa clinical trials in Alabama
5 studies for Hidradenitis Suppurativa are looking for participants at sites in Alabama.
Cities in Alabama
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Birmingham
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Sep 24, 2026 · NCT07783542Regulation of Inflammatory Genes in Hidradenitis Suppurativa
- Whitaker Clinic, Birmingham
RecruitingObservational study
Ages 18 to 89 · All sexes · Updated Sep 21, 2026 · NCT05507125Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US106, Birmingham
- Investigative Site US086, Birmingham
- Investigative Site US098, Montgomery
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06855498Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
- University of Alabama at Birmingham, Birmingham
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06326476Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- University of Alabama At Birmingham, Birmingham
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Aug 6, 2026 · NCT07213973From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.